Trexquant Investment LP Concert Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.77 - $5.24 $204,481 - $284,212	-54,239 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.86 - $13.07 $192,771 - $518,421	39,665 Added 272.16%	54,239 $271,000
Q4 2020 Feb 11, 2021	BUY	$9.48 - $12.84 $138,161 - $187,130	14,574 New	14,574 $184,000
Q2 2020 Aug 07, 2020	SELL	$7.8 - $11.52 $137,521 - $203,109	-17,631 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$5.98 - $13.09 $105,433 - $230,789	17,631 New	17,631 $156,000
Q3 2019 Nov 08, 2019	SELL	$5.88 - $12.35 $67,819 - $142,444	-11,534 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$9.44 - $13.12 $40,912 - $56,862	-4,334 Reduced 27.31%	11,534 $138,000
Q1 2019 May 13, 2019	BUY	$12.07 - $17.54 $191,526 - $278,324	15,868 New	15,868 $192,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.